BACFENSSI Trademark
Serial Number: 79320158 • Registration: 6829818
BACFENSSI is a trademark filed by
PolyPid Ltd.
on July 8, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Bharati Bakshani Ladas & Parry, LLP
1040 Avenue of the Americas
New York
NY 10018
UNITED STATES
Trademark Details
Filing Date
July 8, 2021
Registration Date
August 30, 2022
Published for Opposition
June 14, 2022
Filing History
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 4, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 9, 2022 FICS
FINAL DISPOSITION PROCESSED
Dec 9, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 30, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 30, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 30, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 14, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 14, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 25, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 6, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
May 6, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 6, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
May 6, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 6, 2022 CNEA
EXAMINER'S AMENDMENT ENTERED
May 6, 2022 XAEC
EXAMINERS AMENDMENT -WRITTEN
May 6, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 8, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 7, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 7, 2022 TROA
REFUSAL PROCESSED BY IB
Nov 15, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 28, 2021 RFCS
REFUSAL PROCESSED BY MPU
Oct 28, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 25, 2021 RFCR
NON-FINAL ACTION WRITTEN
Oct 24, 2021 CNRT
ASSIGNED TO EXAMINER
Oct 19, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 24, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 20, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 16, 2021 REPR